In addition to the significant down-regulation of LAML, EZH2 expression was significantly elevated in various cancer types, such as BLCA, BRCA, CESC, COAD, DLBC, GBM, LGG, LIHC, LUSC, OV, READ, STAD, THYM, UCEC, and UCS, consistent with previous experimental studies [17,25,81–88]. This evidence concerns the gene EZH2 and cancer.